Standard Bearer

Standard Bearer is a biotechnology company focused on the development of novel vaccines and diagnostic tools to combat Staphylococcus aureus infections. A spin-off from the University of Arkansas for Medical Sciences (UAMS), the company leverages proprietary research into the molecular pathogenesis of staphylococcal disease. Its lead program is a multi-component vaccine designed to provide broad protection against various strains of S. aureus, including methicillin-resistant (MRSA) varieties. Standard Bearer aims to address the significant clinical burden of surgical site infections and chronic osteomyelitis through targeted immunological interventions. The company's approach focuses on neutralizing key virulence factors to prevent the establishment and persistence of infection.